Diagnosis of biofilm infections: current methods used, challenges and perspectives for the future.
N B S SilvaL A MarquesD D B RöderPublished in: Journal of applied microbiology (2021)
The diagnosis of biofilms continues to be a challenge, and there is no standardized protocol for such a diagnosis in clinical practice. In addition, some proposed methodologies are expensive to require significant amounts of time and a high number of trained staff, making them impracticable for clinical practice. In recent years, mass spectrophotometry/matrix-assisted laser desorption ionization time of flight (MALDI-TOF) has been applied it in biofilm studies. However, due to several problems and limitations of the technique, MALDI-TOF is far from being the gold standard for identifying biofilm formation. The omics analysis may prove to be a promising strategy for the diagnosis of biofilms in clinical laboratories since it allows the identification of pathogens in less time than needed for conventional techniques and in a more specific manner. However, omic tools are expensive and require qualified technical expertise, and an analysis of the data obtained needs to be careful not to neglect subpopulations in the biofilm. More studies must therefore be developed for creating a protocol that guarantees rapid biofilm identification, ensuring greater chances of success in infection control. This review discusses the current methods of microbial biofilm detection and future perspectives for its diagnosis in clinical practice.
Keyphrases
- candida albicans
- biofilm formation
- pseudomonas aeruginosa
- staphylococcus aureus
- clinical practice
- mass spectrometry
- randomized controlled trial
- escherichia coli
- cystic fibrosis
- mental health
- machine learning
- microbial community
- single cell
- big data
- electronic health record
- artificial intelligence
- multidrug resistant